Pınar Koseoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pınar Koseoglu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Filiz Guclu-Geyik
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
2 shared publications - Nihan Erginel-Unaltuna
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
2 shared publications Aslı BAYRAKTAR
İstanbul Yeni Yüzyıl University, Faculty of Arts and Science, Department of Molecular Biology and Genetics
1 shared publication- Aysem Kaya
Department of Biochemistry , Institute of Cardiology, Istanbul University-Cerrahpaşa , Istanbul , Türkiye
1 shared publication Benay Daylan
İstanbul Yeni Yüzyıl University, Faculty of Arts and Science, Department of Molecular Biology and Genetics
1 shared publication- Cagri Gulec
Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
1 shared publication
Latest Publications
- 12 November 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-11
Methylation of the ESR1 promoters in visceral adipose tissue and its relationship with obesity
Background Obesity is associated with decreased ESR1 expression level in visceral adipose tissue. However, it is unclear exactly what mechanisms are responsible for this decline. The aim of this study was to investigate the impact of aberrant methylation of the ESR1 alternative promoters on decreased ESR1 expression and its connection to obesity. Methods Visceral adipose tissues and peripheral blood cells were obtained from 21 patients (non-obese and obese) undergoing inguinal hernia or gallbladder removal. Alternative promoter regions, C, E2 and F of the ESR1 gene, were analyzed by Methylation-Specific PCR (MSP) and mRNA levels were measured by quantitative real-time PCR (qPCR) in both visceral adipose tissue and peripheral blood cells. All statistical analyses were performed by SPSS (23.0). Results The methylation percentage in the three promoter regions of ESR1 was not different in obese individuals compared to non-obese individuals. We observed that promoter C had the highest methylation frequency in obese patients, although it was not statistically significant. Additionally, we observed that the hypermethylation of ESR1’s promoter C was significantly associated with lower mRNA expression level in obesity (p = 0.020). Conclusion This study suggests that methylation of ESR1 promoter C may be a factor in the development of obesity or a consequence of obesity. Further studies with advanced methods and larger study groups are needed to clarify this issue.
- 12 November 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-11
Methylation of the ESR1 promoters in visceral adipose tissue and its relationship with obesity
Background Obesity is associated with decreased ESR1 expression level in visceral adipose tissue. However, it is unclear exactly what mechanisms are responsible for this decline. The aim of this study was to investigate the impact of aberrant methylation of the ESR1 alternative promoters on decreased ESR1 expression and its connection to obesity. Methods Visceral adipose tissues and peripheral blood cells were obtained from 21 patients (non-obese and obese) undergoing inguinal hernia or gallbladder removal. Alternative promoter regions, C, E2 and F of the ESR1 gene, were analyzed by Methylation-Specific PCR (MSP) and mRNA levels were measured by quantitative real-time PCR (qPCR) in both visceral adipose tissue and peripheral blood cells. All statistical analyses were performed by SPSS (23.0). Results The methylation percentage in the three promoter regions of ESR1 was not different in obese individuals compared to non-obese individuals. We observed that promoter C had the highest methylation frequency in obese patients, although it was not statistically significant. Additionally, we observed that the hypermethylation of ESR1’s promoter C was significantly associated with lower mRNA expression level in obesity (p = 0.020). Conclusion This study suggests that methylation of ESR1 promoter C may be a factor in the development of obesity or a consequence of obesity. Further studies with advanced methods and larger study groups are needed to clarify this issue.
- 5 April 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 61 (6) , 2276-2292
Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults
The anti-inflammatory adipokine intelectin-1, which is encoded by the ITLN1 gene, is hypothesized to be linked to the pathogenesis of type 2 diabetes (T2DM) and obesity. The purpose of this study was to examine the effect of the ITLN1 gene polymorphism rs2274907 on obesity and T2DM in Turkish adults. The impact of genotype on lipid profiles and serum intelectin levels in the obese and diabetes groups was also investigated. Randomly selected 2266 adults (mean age, 55.0 ± 11.7 years; 51.2% women) participating in the population-based Turkish adult risk factor study were cross-sectionally analyzed. The genotyping of rs2274907 A > T polymorphism was performed by using the hybridization probe based LightSNiP assay in real-time PCR. T2DM were defined using the criteria of the American Diabetes Association. Obesity was described as Body mass index ≥ 30 kg/m2. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements. According to findings, there was no vital connection between the rs2274907 polymorphism and obesity, T2DM, or serum intelectin-1 level. The TA+AA carriers had significantly higher triglyceride levels (p = 0.007) compared with the TT carriers in both obese and T2DM women when adjusted for relevant covariates. ITLN1 rs2274907 polymorphism is not correlated with the risk of obesity and T2DM and not affect serum ITLN1 levels in Turkish adults. However, this polymorphism appears to be important in regulating triglyceride levels in obese and diabetic women.
- 5 April 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 61 (6) , 2276-2292
Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults
The anti-inflammatory adipokine intelectin-1, which is encoded by the ITLN1 gene, is hypothesized to be linked to the pathogenesis of type 2 diabetes (T2DM) and obesity. The purpose of this study was to examine the effect of the ITLN1 gene polymorphism rs2274907 on obesity and T2DM in Turkish adults. The impact of genotype on lipid profiles and serum intelectin levels in the obese and diabetes groups was also investigated. Randomly selected 2266 adults (mean age, 55.0 ± 11.7 years; 51.2% women) participating in the population-based Turkish adult risk factor study were cross-sectionally analyzed. The genotyping of rs2274907 A > T polymorphism was performed by using the hybridization probe based LightSNiP assay in real-time PCR. T2DM were defined using the criteria of the American Diabetes Association. Obesity was described as Body mass index ≥ 30 kg/m2. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements. According to findings, there was no vital connection between the rs2274907 polymorphism and obesity, T2DM, or serum intelectin-1 level. The TA+AA carriers had significantly higher triglyceride levels (p = 0.007) compared with the TT carriers in both obese and T2DM women when adjusted for relevant covariates. ITLN1 rs2274907 polymorphism is not correlated with the risk of obesity and T2DM and not affect serum ITLN1 levels in Turkish adults. However, this polymorphism appears to be important in regulating triglyceride levels in obese and diabetic women.
- Open Access
- 12 June 2019
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 10 (2) , 209-216
The effects of insulin and glucose on growth and expression of mar regulon in E. coli
Aim:Host factors are known to modulate virulence, antibiotic susceptibility and growth of bacteria. In the present study we aimed to investigate the effect of human insulin and glucose on growth and expression of mar regulon (marA, marR, ompF, acrA, acrB and tolC) of E. coli SPC105. Material and Methods:E. coli SPC105 was grown in tryptic soy broth (TSB-control) and TSB containing 20 µU/mL insulin, 200 µU/mL insulin, 0.1% glucose and 200 µU/mL insulin + 0.1% glucose. Growths were determined via turbidimetric method. Quantitative polymerase chain reaction (qPCR) was used to determine the gene expression levels. Statistical analysis were performed via Tukey’s post hoc-test. Results:According to absorbance values, it has been shown that 0.1% glucose and 200 µU/mL insulin + 0.1% glucose have led a significant decrease on growth. Expression of acrA gene was shown to be decreased in the presence of 200μIU insulin. Expressions of marR and marA were also decreased in 200μU insulin, 0.1 % glucose+200μU insulin and 0.1% glucose added TSB. Decreasing of marA, marR and acrA expressions were shown to be statistically significant (p<0.05). Conclusion:The results of the present study has shown once more that host factors may influence the growth of a bacterium as well as gene expressions associated with antibiotic susceptibilities.
- 12 June 2019
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 10 (2) , 209-216
Open AccessThe effects of insulin and glucose on growth and expression of mar regulon in E. coli
Aim:Host factors are known to modulate virulence, antibiotic susceptibility and growth of bacteria. In the present study we aimed to investigate the effect of human insulin and glucose on growth and expression of mar regulon (marA, marR, ompF, acrA, acrB and tolC) of E. coli SPC105. Material and Methods:E. coli SPC105 was grown in tryptic soy broth (TSB-control) and TSB containing 20 µU/mL insulin, 200 µU/mL insulin, 0.1% glucose and 200 µU/mL insulin + 0.1% glucose. Growths were determined via turbidimetric method. Quantitative polymerase chain reaction (qPCR) was used to determine the gene expression levels. Statistical analysis were performed via Tukey’s post hoc-test. Results:According to absorbance values, it has been shown that 0.1% glucose and 200 µU/mL insulin + 0.1% glucose have led a significant decrease on growth. Expression of acrA gene was shown to be decreased in the presence of 200μIU insulin. Expressions of marR and marA were also decreased in 200μU insulin, 0.1 % glucose+200μU insulin and 0.1% glucose added TSB. Decreasing of marA, marR and acrA expressions were shown to be statistically significant (p<0.05). Conclusion:The results of the present study has shown once more that host factors may influence the growth of a bacterium as well as gene expressions associated with antibiotic susceptibilities.